Pembrolizumab (Keytruda) Shows Promise in DLBCL Study A new CAR T-Cell therapy, given with Pembrolizumab (Keytruda), is proving to be effective in treating diffuse large B-cell lymphoma (DLBCL). Learn more.
Diffuse Large B-cell Lymphoma Clinical Trial Success Story A b-cell lymphoma clinical trial saved Ian Spencer's life. He shares his diffuse large b-cell lymphoma story. Esther Schorr
ASCO 2019: Lymphoma Expert Discusses Advances in Targeted Therapies Joshua Brody, MD, Rebecca Seago-Coyle
The Road to Successful Lymphoma Treatment: Where We Are Headed Stephen M. Ansell, MD, PhD, Andrew Schorr